NCT03892954 (CFs) is a clinical trial in Chronic Fatigue Syndrome (CFS), sponsored by King Saud University.

Who is sponsoring NCT03892954?

NCT03892954 is sponsored by King Saud University.

What condition does NCT03892954 study?

NCT03892954 studies Chronic Fatigue Syndrome (CFS).

Is NCT03892954 still recruiting?

NCT03892954 is currently completed. Last updated 29 March 2019.

Last reviewed 2019-03-29 · How we verify

NCT03892954: CFs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MicroRNAs as Biomarkers of Pain Intensity in Patients With Chronic Fatigue Syndrome (CFS)

Completed Last updated 29 March 2019

What this trial tests

trial in Chronic Fatigue Syndrome (CFS) in 150 participants. Completed in 30 April 2017.

Timeline

1 April 2016

Primary endpoint
15 April 2017

30 April 2017

Quick facts

Lead sponsor	King Saud University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 April 2016
Primary completion	15 April 2017
Estimated completion	30 April 2017

Conditions studied

Chronic Fatigue Syndrome (CFS) — all drugs for Chronic Fatigue Syndrome (CFS) →

Sponsor

King Saud University

Who can join

Adults 12 to 18, any sex, with Chronic Fatigue Syndrome (CFS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MicroRNAs were shown to play an important role in regulating pain-processing in a wide range of experimental models and clinical pain disorders. Thus, the aim of the present study is to evaluate a set of Micro-RNAs as diagnostic biomarkers of pain intensity in adolescents with chronic fatigue syndrome (CFS) and to correlate with inflammatory markers and pain related comorbidities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Fatigue Syndrome (CFS)

Currently open trials in the same condition.

NCT07242573 — Effect of Physical Exercise and Neuromodulation on Pain, Sleep and Fatigue in Patients With Fibromyalgia · NA · recruiting

Other King Saud University trials

Trials by the same sponsor.

NCT07500493 — Tele-Rehabilitation in Adults With Cystic Fibrosis · NA · not yet recruiting
NCT07324044 — Chrono-ALIGN: A Chronotype-Based Chrono-Nutrition Intervention in Post-Bariatric Patients · NA · not yet recruiting
NCT07288385 — Investigating the Feasibility of Combining Virtual Reality and Bilateral Transcranial Direct Stimulation to Improve Uppe · NA · recruiting
NCT07475195 — Oral Probiotics and Denture Care in Saudi Arabia: Evaluating Knowledge, Practices, and the Future of Innovative Hygiene · completed
NCT07159152 — Effects of Coffee Versus Hibiscus Tea Consumption During Prolonged Sitting on Blood Pressure and Heart Rate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03892954 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Saud University
Last refreshed: 29 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03892954.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing